Biotech Breakthrough: FDA Approves First Human Trial for Partial Rejuvenation Therapy in 2026
Life Biosciences secures landmark FDA approval for first human clinical trial testing partial epigenetic reprogramming t…
Life Biosciences secures landmark FDA approval for first human clinical trial testing partial epigenetic reprogramming t…
The European Space Agency (ESA) is set to launch the Copernicus Anthropogenic Carbon Dioxide Monitoring (CO2M) satellite…
Elon Musk's SpaceX is targeting mid-March 2026 for Starship V3's first orbital flight, despite regulatory delays and NAS…
Commonwealth Fusion Systems announces construction of ARC fusion reactor that will power 150,000 homes, marking the dawn…
Groundbreaking research published in Nature Structural & Molecular Biology reveals how CRISPR–Cas9 evolved through molec…
A groundbreaking Princeton University report reveals that advanced plasma diagnostics and AI-powered measurement tools a…
On March 4, 2026, the U.S. Nuclear Regulatory Commission unanimously approved TerraPower's Kemmerer Unit 1, the first co…
The European Space Agency's PLATO mission is set to launch in late 2026 aboard Ariane 6, carrying 26 precision cameras t…
Swiss scientists at EPFL have developed a breakthrough membrane that boosts blue energy—electricity from mixing salt and…
Spanish researchers have successfully decoded elusive Majorana qubits using a novel 'quantum capacitance' technique, bri…
China's EAST fusion reactor has crossed a critical plasma density threshold that scientists once thought unreachable, br…
French Inserm researchers have identified a new mechanism behind cancer metastasis formation. The discovery could revolu…